What are the “known unknowns” about Moderna’s vaccine?

What Are the “Known Unknowns” About Moderna’s Vaccine? | Noubar Afeyan | GZERO World

Moderna co-founder Noubar Afeyan concedes that there is plenty he still doesn't know about his company's COVID-19 vaccine, just as there's plenty he still doesn't know about the virus. But he is confident about one thing: "I view the vaccine as the best mask. It's a molecular mask, and once we have it onboard once, then presumably it will protect us." His conversation with Ian Bremmer was part of the latest episode of GZERO World.

Watch the GZERO World episode: A Shot in the Arm: Moderna's Co-Founder on the COVID-19 Vaccine

More from GZERO Media

Earlier this month, Microsoft released the 2025 TechSpark Impact Report, which highlights how the company is assisting regions across the US in achieving these goals. Since its launch, TechSpark has obtained over $700 million in community funding, supported more than 65,000 people in developing digital skills, and, thanks to the work of TechSpark Fellows, catalyzed $249M+ in funding and upskilled 34,600 individuals across 46 communities — highlighting the ripple effect of local leadership and innovation. Learn more about this progress in the 2025 report here.

People walk past a jewelry store in the Diamond District of Manhattan, New York City, USA, on August 6, 2025.
Jimin Kim / SOPA Images via Reuters Connect

GZERO spoke to Eurasia Group’s Commodities Director Tim Puko to better understand why the diamond industry has tanked, and the consequences of this for geopolitics.

- YouTube

In Ask Ian, Ian Bremmer notes that US–China relations are once again on edge. After Washington expanded export controls on Chinese tech firms, Beijing struck back with new limits on critical minerals. President Trump responded by threatening 100% tariffs, then quickly walked them back.

In this episode of The Ripple Effect: Investing in Life Sciences, host Dan Riskin speaks with Patrick Horber, President of Novartis International, and David Gluckman, Vice Chairman of Investment Banking and Global Head of Healthcare at Lazard. Together, they break down the outsized economic impact of life science innovation, from trillions in US bioscience output to China’s meteoric rise as a global R&D hub.

RPG-7 training of Ukrainian soldiers. November 17, 2024.
  • Adrien Vautier via Reuters Connect

People from different cultures often approach the same problem in different ways. We wondered — would an AI trained and tuned in China approach a complex geopolitical challenge differently than a model created and trained in Europe, or in the United States?

French President Emmanuel Macron speaks to the members of the media, after arriving by plane to attend the Gaza Peace Summit, in Sharm el-Sheikh, Egypt, October 13, 2025.
Yoan Valat/Pool via REUTERS

2: French President Emmanuel Macron rejected calls to resign as his fragile government faces two no-confidence votes this week.